High incidence of skin rash in patients with hairy cell leukemia treated with cladribine.

@article{Ganzel2012HighIO,
  title={High incidence of skin rash in patients with hairy cell leukemia treated with cladribine.},
  author={Chezi Ganzel and Moshe E Gatt and Alexander Maly and Dina Ben-Yehuda and Neta Goldschmidt},
  journal={Leukemia & lymphoma},
  year={2012},
  volume={53 6},
  pages={1169-73}
}
Treatment of hairy cell leukemia (HCL) with cladribine induces durable remissions. Common toxicities are myelosuppression and immunosuppression with low counts of CD4 + T cells. Skin rash (SR) is seldom described. We collected clinical and laboratory data of 35 patients with HCL treated in Hadassah between January 1999 and February 2010, in order to… CONTINUE READING